What Fueled The Previous Growth In The RNA Sequencing Services Market?
The rna sequencing services market has seen considerable growth due to a variety of factors.
• In recent times, the market size for RNA sequencing services has seen an accelerated expansion. It is projected to increase from $3.58 billion in 2024 to $4 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%.
The significant rise in this field during the historical period is tied to the increasing demand for personalized medication, developments in bioinformatics instruments, a heightened emphasis on drug discovery and production, an escalated use of RNA sequencing in agricultural studies, and the widen applications in clinical diagnostics.
What Can Be Expected from the RNA Sequencing Services Market Size?
The rna sequencing services market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size of RNA sequencing services is predicted to experience a swift expansion, reaching a value of $6.13 billion in 2029, with a compound annual growth rate (CAGR) of 11.3%.
The upswing during the forecasted period can be linked to the emergence of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning in data assessment, and the increased research in non-coding RNA biomarkers. Additional factors include the rising request for transcriptomic examination in immunotherapy research and growing collaboration between academia and the industry in genomic investigations. The forecast period will also witness major trends such as the adoption of long-read sequencing, cloud-based study platforms, increasing demand for RNA splicing analysis, and the integration of multi-omics data.
What Are the Critical Driver Fuelling The RNA Sequencing Services Market's Growth?
The surge in necessity for personalized medicine is playing a pivotal role in driving the expansion of the RNA sequencing services market. Personalized medicine implies the adaptation of healthcare treatment to unique individual traits like genetics or lifestyle, with a view to amplify effectiveness and minimize detrimental effects. The escalating need for personalized medicine is stimulated by its inherent capability to proffer more efficient treatments, advancements in the sector of genomics, heightened complexity of diseases, and regulatory backing. RNA sequencing services facilitate the classification of various disease subtypes, discovering biomarkers, the determination of therapeutic targets, predictions of treatment responses and the surveillance of disease progression and treatment outcomes. Personalized medicine methodologies utilize RNA sequencing technologies to deliver customized and efficient medications that target the distinctive molecular characteristics of individual patients. As an illustration, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that in February 2024, the FDA (Food and Drug Administration) sanctioned 16 unique personalized therapies for patients diagnosed with rare diseases in 2023, a significant increase compared to six in 2022. The approved personalized therapies in 2023 also included seven drugs for cancer and three for other diseases and conditions. Consequently, the intensifying demand for personalized medicine is catalyzing the expansion of the RNA sequencing services market in the forthcoming period.
How Is The RNA Sequencing Services Market segmented?
The RNA sequencing services market covered in this report is segmented –
1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)
2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods
3) By Application Area: Research Purposes, Diagnostic Purposes
4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion
2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing
3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing
Pre-Book The RNA Sequencing Services Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The RNA Sequencing Services Market?
Key players in the RNA sequencing services market are prioritizing automation to minimize the risk of human error, exemplified through next-generation sequencing (NGS) assay, with the goal of improving both efficiency and precision in generating and analyzing data. RNA next-generation sequencing (RNA-seq) assays are valuable tools in the domains of molecular biology and genomics, enabling the exploring of a biological sample's transcriptome. For instance, in June 2023, the U.S-based precision medicine technology firm, Tempus, introduced its independent RNA next-generation sequencing assay, Tempus xR. This trailblazing assay, developed for solid tumors, provides an in-depth analysis of the entire transcriptome and draws attention to clinically relevant fusions in over 100 targeted genes, along with altered splicing for MET Exon 14 and EGFRvIII. Understanding the importance of RNA sequencing data, Tempus has historically merged both RNA and DNA sequencing in its standard xT broad-panel assay. Presently, clients can choose to order each test independently or together, and have the option to enhance xR with certain Tempus algorithmic tests. This service accommodates physicians interested in RNA fusions or altered splicing, as well as service providers, investigators, and biopharmaceutical firms aiming for comprehensive RNA sequencing analysis of their existing samples.
Who Are the Key Players In The RNA Sequencing Services Market?
Major companies operating in the RNA sequencing services market are:
• Thermo Fisher Scientific Inc.
• Feng Chi Biotech Corp.
• Illumina Inc.
• Qiagen NV
• BGI Genomics Co. Ltd.
• Azenta Inc.
• Abcam Limited
• Novogene Co. Ltd.
• Genewiz Inc.
• Diagenode LLC
• CD Genomics
• CeGaT GmbH
• Lexogen GmbH
• BaseClear BV
• Active Motif Inc.
• Microsynth AG
• RayBiotech Inc.
• Genomax Technologies Pte. Ltd.
• Phalanx Biotech Group Inc.
• Creative Biogene
• SeqMatic LLC
• Genohub Inc.
• Otogenetics
• LC Sciences
• Admera Health
• Arraystar Inc.
• IGA Technology
• Yaazh Xenomics
What Is The Most Dominant Region In The RNA Sequencing Services Market?
North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
